Oak Street Health, CVS deal would make sense for both companies, says Stifel

Stifel analyst Craig Jones made no change to the firm’s rating on Oak Street Health (OSH) after Bloomberg reported that CVS (CVS) has been in talks to buy the company with a rumored valuation of over $10B. The analyst thinks the deal would make sense for both companies as CVS would achieve its goal of acquiring its way into primary care, and Oak Street has access to a much more substantial balance sheet and would not have to access capital markets at less favorable terms while it continues to move toward profitably in 2026, Jones tells investors in a research note.